12
Participants
Start Date
July 19, 2021
Primary Completion Date
June 9, 2023
Study Completion Date
June 9, 2023
REGEND001
Transplantation of REGEND001 for dose escalation.
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
Peking Union Medical College Hospital
OTHER
Ruijin Hospital
OTHER
The First Affiliated Hospital of Guangzhou Medical University
OTHER
Regend Therapeutics XLotus (Jiangxi) Co, Ltd.
UNKNOWN
Regend Therapeutics
INDUSTRY